Pete Briskman, an Executive Managing Director with JLL, leads the Tenant Advisory and brokerage groups for JLL in Maryland, sits down with BioTalk Host Rich Bendis to talk his role with JLL, his focus on Life Sciences, and vision of the BioHealth Capital Region

Andrea Alms, MS, MBA, Co-Fund Manager of BioHealth Capital Fund, joins Rich Bendis on BioTalk to discuss her background, the world of Angel Investment, and her vision for the Fund

Chuck Morton, Partner, Venable, LLP, joins BioTalk to discuss the local entrepreneurial and business ecosystem, regionalism, and the BioHealth Capital Region

Recorded at the BioHealth Capital Region Investor Forum: Christian Barrow, Executive Director of Life Sciences Banking with JPMorgan Chase, guests on BioTalk to talk about his background working with life science companies, healthcare Investing, and the BioHealth Capital Region.

Michael Lenardo, M.D., Chief, Molecular Development of the Immune System Section NIAID/DIR, joins Rich Bendis on BioTalk to discuss his work at NIH, his recent election to the National Academy of Medicine, and advice for fellow scientists

Super Angel Investor, Faz Bashi, MD, guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about his background in Immunology/Virology, Venture Investing, and coming to the BioHealth Capital Region.

Cartesian Therapeutics' President & CEO Murat Kalayoglu, MD, Ph.D., guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about developing novel cell and gene therapies, building his company in the region, and also being an investor.

Gentian's CEO Dr. Hilja Ibert, Ph.D., guests on BioTalk from the BioHealth Capital Region Investor Conference to talk about their presence in the US market, biomarkers, and innovate diagnostic efficiency

Carolyn Yarina, CEO & Co-Founder of Sisu Global Health, Joins Rich Bendis on BioTalk to Discuss Her Career, Sisu's Technology, and Thoughts on Entrepreneurism

NEA Partner, Sara Nayeem, M.D., Joins Rich Bendis on BioTalk to Discuss Her Career, Venture Capital, and BioPharma